BriaCell Therapeutics Corp. (BCTX) KPIs and segments

BCTXNasdaqPharmaceutical PreparationsFiscal year ends July 31Also trades as BCTXL, BCTXZ

Financials through Q4 FY2026, quarter ended Jul 31, 2026Last filing: 10-K on Oct 28, 2026Score 4/30

$3.51−0.08 (-2.23%)

Close on Nov 12, 2026Market cap $30.65MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive BriaCell Therapeutics's business

Coming soon

This tab will track the numbers specific to BriaCell Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?